Riley Jennifer — SEC Form 4 filings

SEC reporting owner CIK 2047607. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-12.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2025-01-03 to 2026-08-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Avalo Therapeutics, Inc. (AVTX)Chief Strategy Officer61 leg · 2,655 sh · $52,0125

Form 4 filings — Riley Jennifer

FiledFormIssuerReported transactionsSource
2026-08-124Avalo Therapeutics, Inc. (AVTX)Sale (S): 2,655 @ $19.59EDGAR
2026-06-124Avalo Therapeutics, Inc. (AVTX)Tax withholding (F): 588 @ $13.10EDGAR
2026-05-264Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 34,200 @ $0EDGAR
2026-03-024Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 95,000 (derivative) @ $0EDGAR
2025-12-124Avalo Therapeutics, Inc. (AVTX)Tax withholding (F): 637 @ $4.10EDGAR
2025-01-034Avalo Therapeutics, Inc. (AVTX)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2047607 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →